Aldose reductase is a potent regulator of TGF-β1 induced expression of fibronectin in human mesangial cells

[1]  S. Chung,et al.  Aldose Reductase Regulates Hepatic Peroxisome Proliferator-activated Receptor α Phosphorylation and Activity to Impact Lipid Homeostasis* , 2008, Journal of Biological Chemistry.

[2]  A. Demaine,et al.  High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathy. , 2008, Biochimica et biophysica acta.

[3]  D. Srivastava,et al.  Endotoxin-Induced Cardiomyopathy and Systemic Inflammation in Mice Is Prevented by Aldose Reductase Inhibition , 2006, Circulation.

[4]  Nong Zhang,et al.  Aldose reductase regulates TGF‐β1‐induced production of fibronectin and type IV collagen in cultured rat mesangial cells , 2006, Nephrology.

[5]  Aruni Bhatnagar,et al.  Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. , 2005, Endocrine reviews.

[6]  Zhang Nong.  Effect of transforming growth factor-β1 on aldose reductase expression in rat mesangial cells and anti-Thy1 glomerulonephritis , 2005 .

[7]  J. Trent,et al.  Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids* , 2004, Journal of Biological Chemistry.

[8]  O. El-Kabbani,et al.  Aldose reductase structures: implications for mechanism and inhibition , 2004, Cellular and Molecular Life Sciences CMLS.

[9]  B. Aggarwal,et al.  Aldose Reductase Mediates Mitogenic Signaling in Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[10]  N. Zhang,et al.  [Effect of aldose reductase expression by transforming growth factor-beta1 on rat mesangial cell]. , 2001, Zhonghua yi xue za zhi.

[11]  C. Yabe-Nishimura,et al.  Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. , 2000, Molecular pharmacology.

[12]  D. Harrison,et al.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. , 1999, The Biochemical journal.

[13]  R. Portman,et al.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. , 1999, Kidney international.

[14]  J. Kopp,et al.  Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. , 1999, Journal of the American Society of Nephrology : JASN.

[15]  S. Watowich,et al.  Structural and kinetic determinants of aldehyde reduction by aldose reductase. , 1999, Biochemistry.

[16]  J. Kopp,et al.  Renal Expression of Fibrotic Matrix Proteins and of Transforming Growth Factor- b (TGF- b ) Isoforms in TGF- b Transgenic Mice , 1999 .

[17]  T. Srivastava,et al.  High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood , 1999, Pediatric Nephrology.

[18]  H. Schnaper,et al.  Regulation of human mesangial cell collagen expression by transforming growth factor-β1. , 1998, American journal of physiology. Renal physiology.

[19]  F. V. van Kuijk,et al.  Reduction of 4-hydroxynonenal and 4-hydroxyhexenal by retinal aldose reductase. , 1998, Biochemical and biophysical research communications.

[20]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[21]  C. Yabe-Nishimura,et al.  Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. , 1998, Pharmacological reviews.

[22]  T. Flynn,et al.  A new nomenclature for the aldo-keto reductase superfamily. , 1997, Biochemical pharmacology.

[23]  M. Kitamura,et al.  TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Y. Kaneda,et al.  Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. , 1996, Kidney international.

[25]  G. King,et al.  The cellular and molecular mechanisms of diabetic complications. , 1996, Endocrinology and metabolism clinics of North America.

[26]  M. Schwartz,et al.  The racial prevalence of glomerular lesions in nephrotic adults. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[28]  Y. Kaneda,et al.  Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. , 1993, The Journal of clinical investigation.

[29]  K. Yoshioka,et al.  Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. , 1993, Laboratory investigation; a journal of technical methods and pathology.